Results 201 to 210 of about 28,760 (245)
Mitochondria‐targeted nanotherapies emerge as a promising strategy for combating aging‐associated neurodegenerative disorders (NDs) by restoring mitochondrial function, reducing oxidative stress, and improving neuronal survival. Recent advances in nanotechnology, therapeutic delivery, and translational research are highlighted, providing insights into ...
Dnyandev G. Gadhave +8 more
wiley +1 more source
Visual and Patient-Reported Outcomes After Bilateral Implantation of Two Enhanced Monofocal IOLs. [PDF]
Giglio R +9 more
europepmc +1 more source
A hyaluronic acid/tannic acid‐engineered Prussian blue oxygen nanogenerator loaded with IR780 is developed to enhance melanoma phototherapy. By integrating tumor targeting, oxygen self‐supply, and dual‐mode glutathione depletion, the nanoplatform effectively overcomes hypoxia and antioxidant defenses, potentiating synergistic photothermal/photodynamic ...
Chai‐How Hsu +7 more
wiley +1 more source
Microperimetry-Based Fixation Training in Patients with Age-Related Macular Degeneration (AMD). [PDF]
Ciszewska K +3 more
europepmc +1 more source
Rare‐Earth–Functionalized Carbon Dot Hydrogels as Mechanically Robust Antibacterial Wound Dressings
The schematic depicts a dynamically cross‐linked PVA hydrogel network in which reversible borate ester bonds and hydrogen‐bonding interactions integrate lanthanum‐doped carbon dots (La‐CDs) and dipotassium glycyrrhizinate (DPG) to form a mechanically robust, multifunctional matrix.
Shih‐Han Tsai +4 more
wiley +1 more source
Using pixel‐aware digital light processing, the authors created high‐resolution, dissolvable microneedles from a PEGDA/VP matrix. These microneedles encapsulate curcumin and 5‐fluorouracil and dissolve in the skin, co‐delivering drugs directly to tumours.
Rutuja N. Meshram, Dimitrios A. Lamprou
wiley +1 more source
An Update on Intraocular Lens Technology for Presbyopia Correction and Visual Outcomes. [PDF]
Niknahad A +5 more
europepmc +1 more source
Making the Case for Organ‐on‐Chip Platforms in Long‐Acting Therapeutics Development
LATs release drug from a tissue‐resident depot over weeks to months, improving adherence, but their development is hampered by preclinical models that cannot reproduce the coupled tissue processes, sustained release, local microenvironment change, interstitial transport, immune and foreign‐body responses, and clearance that govern depot performance in ...
Charlie Gowans +7 more
wiley +1 more source
Biofeedback Fixation Training in the Rehabilitation of Patients with Geographic Atrophy. [PDF]
Vörös K +8 more
europepmc +1 more source
Advances in Technology-Assisted Visual Rehabilitation Therapies: Scoping Review. [PDF]
Saiz Briceño M +4 more
europepmc +1 more source

